Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Goodwill (2020 - 2025)

Historic Goodwill for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $7.5 million.

  • Bioventus' Goodwill changed 0.0% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $7.5 million for FY2024, which is 0.0% changed from last year.
  • Per Bioventus' latest filing, its Goodwill stood at $7.5 million for Q3 2025, which was down 0.0% from $7.5 million recorded in Q2 2025.
  • Bioventus' 5-year Goodwill high stood at $148.0 million for Q2 2022, and its period low was $7.5 million during Q4 2022.
  • Its 5-year average for Goodwill is $37.0 million, with a median of $7.5 million in 2022.
  • Per our database at Business Quant, Bioventus' Goodwill soared by 19643.17% in 2021 and then tumbled by 9495.7% in 2023.
  • Bioventus' Goodwill (Quarter) stood at $147.6 million in 2021, then crashed by 94.95% to $7.5 million in 2022, then changed by 0.0% to $7.5 million in 2023, then changed by 0.0% to $7.5 million in 2024, then changed by 0.0% to $7.5 million in 2025.
  • Its Goodwill stands at $7.5 million for Q3 2025, versus $7.5 million for Q2 2025 and $7.5 million for Q1 2025.